Ophthotech Appoints CFO
This article was originally published in Scrip
Executive Summary
Ophthotech Corporation has appointed Glenn P. Sblendorio executive vice president, chief operating officer and chief financial officer (CFO) – effective April 1, 2016. The company also announced that the current executive vice president and chief financial and business officer, Michael G. Atieh will be retiring – effective April 1, 2016. Sblendorio will be joining Ophthotech from The Medicines Company, where he most recently served as president and CFO. Previously he held various senior management positions at Hoffmann-La Roche, Inc., Eyetech Pharmaceuticals Inc. and MPM Capital Advisors, LLC.